M&T Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

M&T Bank’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,501	Closed	-$512K	–	1668
2017 Q4	$512K	Sell	9,501 -52	-0.5%	-$2.85K	﹤0.01%	992
2017 Q3	$545K	Sell	9,553 -301	-3%	-$17.6K	﹤0.01%	948
2017 Q2	$592K	Sell	9,854 -1,995	-17%	-$114K	﹤0.01%	920
2017 Q1	$646K	Buy	+11,849	New	+$584K	﹤0.01%	903

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

M&T Bank's BIVV Position: Q1 2018 in Review

M&T Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 9,501 shares — an estimated $512K sold.

M&T Bank first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $646K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

M&T Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
M&T Bank sold 9,501 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $512K.
M&T Bank first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
M&T Bank's Bioverativ Inc. Common Stock position peaked at $646K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on M&T Bank's 13F filing for Q1 2018, filed 4 May 2018.